Gut bacteria study in critically ill patients
Part of Infections clinical trials.
This study looks at the bacteria in the gut of people who are very ill in the hospital. It may help doctors understand how gut health affects recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 and under 85 years old.
- You are currently in the intensive care unit (ICU) or a similar critical care setting.
- You do not have HIV or AIDS.
- You are not pregnant.
- You are not currently incarcerated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people’s blood to see if they already have antibodies that recognize Pseudomonas aeruginosa, a type of bacteria. If you qualify for the prospective part, they may collect blood samples at Grenoble University Hospital and use your results to support future treatment testing.
This study tests a specific antibiotic plan for adults with a hard-to-treat Pseudomonas infection that needs IV medicine. It aims to find the best way to treat these serious infections.
This study looks at how certain genes and biofilms (a sticky layer bacteria make) work in pseudomonas bacteria found in patient samples. It may help doctors understand how to better treat infections caused by this bacteria.
This study looks at patterns of immune cells in people who are critically ill with sepsis caused by Pseudomonas aeruginosa bacteria. It may help doctors better understand how the immune system responds and improve care for this serious infection.
This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.
This trial tests a new imaging method to quickly find Pseudomonas aeruginosa bacteria in lung fluid, and then see how well treatment works. It aims to help doctors diagnose and treat this tough infection faster.
Hear when a new Pseudomonas Aeruginosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.